Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Reexamination Certificate
2004-11-22
2009-11-03
McGarry, Sean R (Department: 1635)
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
C435S480000, C435S481000, C435S486000, C435S488000, C435S091400
Reexamination Certificate
active
07611883
ABSTRACT:
The invention relates to a system for stable maintenance of a plasmid, to host cells for use in this system and to methods of using the system to obtain a plasmid useful in medical applications. In particular, the invention provides transformed host cell containing: i) a chromosomal gene which inhibits cell growth; and ii) a plasmid encoding an antisense sequence, wherein the antisense sequence encoded by the plasmid inhibits the action of the chromosomal gene, thereby permitting cell growth and a method for stable maintenance of a plasmid in a host cell in vivo.
REFERENCES:
patent: 6413768 (2002-07-01), Galen
patent: 2006/0063232 (2006-03-01), Grabherr et al.
patent: 0 851 932 (1998-07-01), None
patent: 97/14805 (1997-04-01), None
patent: 02/079467 (2002-10-01), None
Shohat, et al. (1987) Inhibition of Cell Growth Mediated by Plasmids Encoding p53. Oncogene, v.1(3):277-283.
Hu and Davidson (1987) The Inducible Lac Operator-Repressor System is Functional in Mammalian Cells. Cell, v.48(4):555-66.
Adhya, S., “The Galactose Operon,” inEscherichia coliandSalmonella typhimurium, Eds. J. L. Ingraham et al., 1987, Amer. Soc. Micro., 1503-1512.
Altboum, Z. et al., “AttenuatedShigella flexneri2a Delta guaBA strain CVD 1204 expressing enterotoxigenicEscherichia coli(ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection,”Infect Immun., 2001, 69(5), 3150-3158.
Baik, H. S. et al., “The acid tolerance response ofSalmonella typhimuriumprovides protection against organic acids,”Microbiology, 1996, 142(Pt 11), 3195-3200.
Bebbington, C. R. et al., “High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker,”Bio/Technology, 1992, 10(2), 169-175.
Beckwith, J., “The Lactose Operon,” inEscherichia coliandSalmonella typhimurium, Eds. Ingraham, J. L. et al., 1987, Amer. Soc. Micro., 1444-1452.
Bijlsma, J. J. et al., “Identification of loci essential for the growth ofHelicobacter pyloriunder acidic conditions,”J. Infect. Dis., 2000, 182(5), 1566-1599, Epub Oct. 9, 2000.
Borezee, E. et al., “SvpA, a novel surface virulence-associated protein required for intracellular survival ofListeria monocytogenes,”Microbiology, 2001, 147(Pt 11), 2913-2923.
Bouvier, J. et al., “Nucleotide sequence and expression of theEscherichia colidapB gene,”J. Biol. Chem., 1984, 259(23), 14829-14834.
Brantl, S., “Antisense RNAs in plasmids: Control of replication and maintenance,”Plasmid, Nov. 2002, 48(3), 165-173.
Burke, M. et al., “MutantEscherichia coliarginine repressor proteins that fail to bind L-arginine, yet retain the ability to bind their normal DNA-binding sites,”Mol. Microbiol., 1994, 13(4), 609-618.
Castanie-Cornet and Foster, J. W., “Escherichia coliacid resistance: cAMP receptor protein and a 20 bp cis-acting sequence control pH and stationary phase expression of the gadA and gadBC glutamate decarboxylase genes,”Microbiology, 2001, 147(Pt 3), 709-715.
Cesareni, G. et al., “Control of Co1E1 DNA replication: the rop gene product negatively affects transcription from the replication primer promoter,”Proc. Natl. Acad. Sci.USA, Oct. 1982, 79, 6313-6317.
Chan, P. T. et al., “Nucleotide sequence and gene organization of Co1E1 DNA,”J. Biol. Chem, 1985, 260(15), 8925-8935.
Cohen, J. S., “Designing antisense oligonucleotides as pharmaceutical agents,”Trends in Pharm. Sci., 1989, 10(11), 435-437.
Cooney, M. et al., “Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro,”Science, 1988, 241(4864), 456-459.
Cotter, P. D. et al., “Analysis of the role of theListeria monocytogenesF0F1 -AtPasc operon in the acid tolerance response,”Int. J. Food Microbiol., 2000, 60(2-3), 137-146.
Cranenburgh, R. M. et al., “Escherichia colistrains that allow antibiotic-free plasmid selection and maintenance by repressor titration,”Nucl. Acids Res., 2001, 29(5), e26-e27.
Cronan et al., “Biosynthesis of membrane lipids,” inEscherichia coliandSalmonella typhimurium: cellular and molecular biology, vol. 1, Neidhardt, F. C. (ed.) American Society of Microbiology, Washington, D. C., 1987, pp. 474-497.
del Solar, G. et al., “Replication and control of circular bacterial plasmids,”Microbiol. And Molec. Biol. Rev., 1998, 62(2), 434-363.
Delihas, N., “Regulation of Gene Expression by Trans-encoded Antisense RNAs,”Molecular Microbiology, 1995, 15(3), 411-414.
Dervan, P. B. et al. “Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation,”Science, 1991, 251(4999), 1360-1363.
Dickson, R. C. et al., “Genetic regulation: the Lac control region,”Science, 1975, 187(4171), 27-35.
Dunn, T. M. et al., “An operator at -280 base pairs that is required for repression of araBAD operon promoter: addition of DNA helical turns between the operator and promoter cyclically hinders repression,”Proc. Natl. Acad. Sci., 1984, 81 (16), 5017-5020.
Feberwee, A. et al., “The spread ofSalmonella gallinarum9R vaccine strain under field conditions,”Avian Dis., 2001, 45(4), 1024-1029.
Galen, J. E. et al., “Optimization of plasmid maintenance in the attenuated live vector vaccine strainSalmonella typhiCVD 908-htrA,”Infect. Immun., 1999, 67(12), 6424-6433.
Garmory, H. S. et al., “Salmonellavaccines for use in humans: present and future perspectives,”FEMS Microbiology Reviews, 2002, 26(4), 339-353.
Gossen, M. et al., “Inducible gene expression systems for higher eukaryotic cells,”Current Opinions in Biotechnology, 1994, 5(5), 516-520.
Hanna, M. N. et al., “uvrA is an acid-inducible gene involved in the adaptive response to low pH inStreptococcus mutans,” J. Bacteriol., 2001, 183(20), 5964-5973.
Hare, D. L. et al., “Regulated high-level expression of theHerpes simplextype I thymidine kinase gene inEscherichia coli,” Gene, 1984, 32, 117-128.
Hiszczynska-Sawicka et al., “Effect of Integration Host Factor on RNA II Synthesis in Replication of Plasmid Containingorip 15A,”Plasmid, 1998, 40, 150-157.
Hochschild, A. et al., “How lambda repressor and lambda Cro distinguish between OR1 and OR3,”Cell, 1986, 47(5), 807-816.
Introduction to Lambda Phages, in Current Protocols in Molecular Biology, Eds. Ausubel, et al., 1994, Section III, Unit 1.9.
Lee, J. S. et al., “Complexes formed by (pyrimidine)n . (purine)n DNAs on lowering the pH are three-stranded,”Nucleic Acids Res., 1979, 6(9), 3073-3091.
Liang, S. et al., “Activities of constitutive promoters inEscherichia coli,”J. Mol. Biol., 1999, 292, 19-37.
Link, A. J. et al., “Methods for generating precise deletions and insertions in the genome of wild-typeEscherichia coli: application to open reading frame characterization,”J. Bacteriol., 1997, 179(20), 6228-6237.
McMacken et al. InEscherichia coliandSalmonella typhimurium: cellular and molecular biology, Neidhardt, F. C. (ed.) American Society of Microbiology, Washington, D. C. 1987, pp. 564-612.
Morona, R. et al., “Construction of plasmid vectors with a non-antibiotic selection system based on theEscherichia colithyA+ gene: application to cholera vaccine development,”Gene., 1991, 107, 139-144.
Murphy, K. C., “Use of bacteriophage lambda recombination functions to promote gene replacement inEscherichia coli,” J. Bacteriol., 1998, 180(8), 2063-2071.
Ogden, K. L. et al., “An Adjustable Expression System for Controlling Growth Rate, Plasmid Maintenance, and Culture Dynamics,”Biotech. Bioeng., 1992, 40, 1027-1038.
Okano, H. et al., “Myelin basic protein gene and the function of antisense RNA in its repression in myelin-deficient mutant mouse,”J. Neurochem, 1991, 56(2), 560-567.
Oyston, P. C.
Cobra Biologics Limited
McGarry Sean R
Pitrak Jennifer
Woodcock & Washburn LLP
LandOfFree
Plasmid maintenance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plasmid maintenance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasmid maintenance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4107196